Seres Therapeutics (MCRB) Inventory Average (2023 - 2024)

Seres Therapeutics (MCRB) posted Inventory Average of $47.5 million for Q2 2024, up 32.6% sequentially from $35.8 million in Q1 2024.

Seres Therapeutics (MCRB) Inventory Average (2023 - 2024) Analysis & Trends

Seres Therapeutics has reported Inventory Average for 2 years, with the latest figure at $47.5 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Vertex Pharmaceuticals	138.41 Bn	130.56 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	86.12 Bn	78.12 Bn	3.93 Bn	3.09 Bn
3	Argenx Se	64.41 Bn	59.23 Bn	1.37 Bn	-
4	Moderna	57.56 Bn	52.43 Bn	52.00 Mn	213.00 Mn
5	BeOne Medicines	42.06 Bn	36.96 Bn	1.53 Bn	707.10 Mn
6	Alnylam Pharmaceuticals	30.95 Bn	27.65 Bn	992.69 Mn	90.57 Mn
7	BioNTech SE	27.48 Bn	9.09 Bn	668.28 Mn	196.36 Mn
8	Insmed	27.31 Bn	26.15 Bn	358.27 Mn	137.65 Mn
9	Royalty Pharma	27.04 Bn	26.20 Bn	-	-
10	Seres Therapeutics	43.87 Mn	43.87 Mn	-	-

Download Data